JMIR Publications

ABSTRACT

Background:

Machine learning (ML) and deep learning (DL) methods have recently garnered a great deal of attention in the field of cancer research by making a noticeable contribution to the growth of predictive medicine and modern oncological practices. Considerable focus has been particularly directed toward hematologic malignancies because of the complexity in detecting early symptoms. Many patients with blood cancer do not get properly diagnosed until their cancer has reached an advanced stage with limited treatment prospects. Hence, the state-of-the art revolves around the latest artificial intelligence (AI) applications in hematology management.

Objective:

This comprehensive review provides an in-depth analysis of the current AI practices in the field of hematology. Our objective is to explore the ML and DL applications in blood cancer research, with a special focus on the type of hematologic malignancies and the patient’s cancer stage to determine future research directions in blood cancer.

Methods:

We searched a set of recognized databases such as Scopus, Springer, and Web of Science using a selected number of keywords. We included studies written in English published between 2015 until 2021. For each study, we identified the ML and DL techniques used and we highlighted the performance of each model.

Results:

Using the aforementioned inclusion criteria, the search resulted in 567 papers, of which 144 were selected for review.

Conclusions:

The current literature suggests that the application of AI in the field of hematology has generated impressive results in the screening, diagnosis, and treatment stages. Nevertheless, optimizing the patient’s pathway to treatment requires a prior prediction of the malignancy based on the patient’s symptoms or blood records, which is an area that has still not been properly investigated. Clinical Trial: NA